GlassScriptPhysician profile
Randall James Contento
NPI 1396931481
$3,810.82
in general payments reported to CMS, 2019-2025
47 companies · $635 in 2025
The $635 reported for 2025 was more than what 78% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $394 · 2021: $417 · 2022: $681 · 2023: $724 · 2024: $554 · 2025: $635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,913.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $337.95 | 2022-2024 | 7 X 23mm Citrelock Implant, Ortholoc 3di Crosscheck, Ortholoc 2 Lapifuse |
| Convatec INC. | $328.68 | 2023-2025 | |
| Depuy Synthes Sales INC. | $303.94 | 2021-2025 | N/A |
| Horizon Therapeutics Plc | $254.53 | 2019-2023 | Krystexxa |
| Smith+Nephew, INC. | $220.37 | 2019-2025 | Collagenase Santyl, Regranex |
| Musculoskeletal Transplant Foundation INC. | $208.83 | 2020-2021 | |
| Nevro Corp. | $182.66 | 2022-2024 | Senza |
| Paratek Pharmaceuticals, INC. | $162.11 | 2019-2023 | Nuzyra |
| Organogenesis INC. | $131.48 | 2019-2024 | Puraply |
| Globus Medical, INC. | $114.92 | 2025 | Senza, Omnia |
| Peerless Surgical INC. | $112.07 | 2019-2024 | |
| Triad Life Sciences INC. | $105.49 | 2022 | |
| Abbvie INC. | $97.39 | 2023-2024 | Dalvance |
| Tactile Systems Technology INC | $93.83 | 2021-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Melinta Therapeutics, LLC | $83.83 | 2019-2021 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $77.23 | 2023 | Xperience, Blastx, Surgx |
| Zimvie INC. | $71.89 | 2023 | |
| Bioventus LLC | $58.95 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Curonix LLC | $53.67 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Grt US Holding, INC. | $52.97 | 2020-2022 | |
| Arthrosurface Incorporated | $52.63 | 2019 | |
| Alfasigma USA, INC. | $49.95 | 2021-2022 | |
| Aroa Biosurgery Incorporated | $44.94 | 2024 | |
| Amgen INC. | $42.28 | 2024-2025 | Krystexxa |
| Orthofix Medical, INC. | $40.32 | 2023 | Physio-Stim |
| Medtronic, INC. | $40.17 | 2022-2023 | Intellis Adaptivestim |
| Nabriva Therapeutics, Plc | $39.91 | 2022 | |
| Heron Therapeutics, INC. | $36.97 | 2021 | |
| Sanara Medtech INC. | $36.67 | 2023-2024 | Celleraterx |
| Koya Medical, INC. | $36.32 | 2025 | Dayspring, Koya Medical |
| Hikma Pharmaceuticals USA | $34.91 | 2021-2022 | |
| Treace Medical Concepts, INC. | $33.86 | 2022-2025 | |
| Acera Surgical, INC. | $29.28 | 2021 | |
| Linvatec Corporation | $24.42 | 2019 | |
| Allergan, INC. | $24.09 | 2020 | |
| Abbott Laboratories | $23.35 | 2025 | Eterna |
| Baudax Bio INC. | $20.55 | 2020 | |
| Averitas Pharma INC. | $20.53 | 2023 | Qutenza |
| Checkpoint Surgical, INC | $18.17 | 2025 | Checkpoint Stimulators |
| Almatica Pharma LLC | $15.08 | 2025 | Teriparatide |
| Osiris Therapeutics INC. | $15.05 | 2019 | |
| Reprise Biomedical, INC. | $14.92 | 2024 | Miro3d |
| Zimmer Biomet Holdings, INC. | $13.23 | 2019 | |
| Advanced Oxygen Therapy INC. | $13.15 | 2023 | Topical Oxygen Chamber For Extremities |
| Sebela Pharmaceuticals INC. | $12.99 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.74 | 2023 | Seglentis |
| Pfizer INC. | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Contento listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.